Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury

NCT00557973 is registered in ClinicalTrials.gov with XenoPort, Inc. as lead sponsor.

NCT NCT00557973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00557973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Lead sponsor
XenoPort, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2007
Completion date
April 30, 2009
Enrollment
37 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

muscle spasticity